[Edaily Reporter Shin Ha-yeon ] BEAUTYSKIN Co., Ltd.(406820)announced on the 16th that it has signed a cosmetics supply contract worth 30 billion won with China’s GUANGZHOU QIANYU BRAND MANAGEMENT CO. This amount represents 54.62% of the company’s recent revenue. The contract is valid through December 31, 2029.
Disclosure Plus
BEAUTYSKIN Co., Ltd. Signs 30 Billion Won Cosmetics Supply Contract
Economy
Corporation
IT·Science
Economy
[VC's Pick] The AI That Played a Match Against Lee Sedol 9-dan… Enhance Secures 51.2 Billion Investment
This week (September 14–18), startups in various fields—including medical artificial intelligence (AI), content solutions, and content tech—secured investments from venture capital (VC) firms and acce…
Corporation
Kang Seong-min, CEO of PeopleBio, Inc.: “Full-Scale Launch of LDT and Diagnostic Kit Business in the U.S. … Revenue to Become Apparent Starting Next Year”
“Building on our designation as an innovative medical device by the U.S. Food and Drug Administration (FDA), we plan to establish a local subsidiary within this year. Next year, we will launch laborat…
IT·Science
Opacalim Clinical Trials Paused… A Closer Look at the Preconditions for SK BIOPHARMACEUTICALS’s 2.3 Trillion Won Deal
SK BIOPHARMACEUTICALS(326030)has drawn attention by repeatedly emphasizing that the deal to acquire “Opacalym” (BHV-7000), a new drug candidate for epilepsy, from the U.S. biotech company Biohaven is …